{"id":11080,"date":"2024-12-11T15:21:41","date_gmt":"2024-12-11T14:21:41","guid":{"rendered":"https:\/\/extali.eu\/docs\/5-pruefung\/5-3-umgang-mit-risiken-und-chancen\/5-3-18-ze-konferenz-fallbesprechungen-morbiditaets-und-mortalitaetskonferenz\/"},"modified":"2025-02-04T13:38:25","modified_gmt":"2025-02-04T12:38:25","slug":"5-3-18-ze-conference-case-discussions-morbidity-and-mortality-conference","status":"publish","type":"docs","link":"https:\/\/gutehospitalpraxis.de\/en\/handbuch\/5-pruefung\/5-3-umgang-mit-risiken-und-chancen\/5-3-18-ze-konferenz-fallbesprechungen-morbiditaets-und-mortalitaetskonferenz\/","title":{"rendered":"5.3.18 ZE conference, case discussions, morbidity and mortality conference"},"content":{"rendered":"
Adverse events (morbidity and mortality) are reported and discussed in the organisation's specialist departments at fixed intervals or for specific reasons. Corrective measures are proposed and followed up. The conferences are recorded. The minutes are forwarded to the department responsible for AEs.<\/p>\n\n\n\n
QM-RL:2015 Part B \u00a7 1 Sentence 6; DIN EN ISO 9001:2015 and DIN EN 15224:2017 9.3.1 h)<\/em><\/p>\n\n\n\n Clinics that agree to organise such conferences.<\/p>\n\n\n\nArea of application<\/h2>\n\n\n\n
Description of the<\/h2>\n\n\n\n